| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Jonathan Blay | Q56256636 |
| P2093 | author name string | Cynthia Lee Richard | |
| P2860 | cites work | HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor | Q22242268 |
| Involvement of chemokine receptors in breast cancer metastasis | Q24290909 | ||
| Genomic organization and functional characterization of the chemokine receptor CXCR4, a major entry co-receptor for human immunodeficiency virus type 1 | Q24310870 | ||
| The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry | Q24315492 | ||
| Cloning of a human seven-transmembrane domain receptor, LESTR, that is highly expressed in leukocytes | Q24324518 | ||
| MicroRNAs control translation initiation by inhibiting eukaryotic initiation factor 4E/cap and poly(A) tail function | Q24538996 | ||
| Directed migration of neural stem cells to sites of CNS injury by the stromal cell-derived factor 1alpha/CXC chemokine receptor 4 pathway | Q24558745 | ||
| Expression of functional CXCR4 chemokine receptors on human colonic epithelial cells | Q24563114 | ||
| MicroRNA-dependent localization of targeted mRNAs to mammalian P-bodies | Q24681266 | ||
| Expression pattern of CXC chemokine receptor-4 is correlated with lymph node metastasis in human invasive ductal carcinoma | Q24803472 | ||
| International union of pharmacology. XXII. Nomenclature for chemokine receptors | Q28145705 | ||
| Sequential induction of prostaglandin E and D synthases in inflammation | Q28186256 | ||
| Prostaglandins and leukotrienes: advances in eicosanoid biology | Q28208246 | ||
| Altered eicosanoid levels in human colon cancer | Q28255943 | ||
| The nuclear eicosanoid receptor, PPARgamma, is aberrantly expressed in colonic cancers | Q28262445 | ||
| The chemokine SDF-1/CXCL12 binds to and signals through the orphan receptor RDC1 in T lymphocytes | Q28267757 | ||
| Genomic organization and promoter characterization of human CXCR4 gene | Q28271622 | ||
| Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer | Q28274188 | ||
| Quantification of prostaglandin D synthetase in cerebrospinal fluid: a potential marker for brain tumor | Q28290831 | ||
| CXCR4 regulates growth of both primary and metastatic breast cancer | Q28296113 | ||
| Retention of CXCR4 in the endoplasmic reticulum blocks dissemination of a T cell hybridoma | Q28344144 | ||
| Ligands for peroxisome proliferator-activated receptorgamma and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice | Q28368272 | ||
| The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract | Q28504884 | ||
| Adenosine inhibits activation-induced T cell expression of CD2 and CD28 co-stimulatory molecules: role of interleukin-2 and cyclic AMP signaling pathways | Q28511859 | ||
| Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development | Q28512895 | ||
| 15-Hydroxyprostaglandin dehydrogenase is down-regulated in colorectal cancer | Q28592082 | ||
| Tumour-educated macrophages promote tumour progression and metastasis | Q29614307 | ||
| siRNAs can function as miRNAs | Q29615070 | ||
| 15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma | Q29615221 | ||
| An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma) | Q29615693 | ||
| Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1 | Q29616092 | ||
| The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1 | Q29616093 | ||
| The biology of chemokines and their receptors | Q29619170 | ||
| A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation | Q29619212 | ||
| Gene expression of cyclooxygenase-2, group II and cytosolic phospholipase A2 in human colorectal cancer | Q77703474 | ||
| Expression of CXC chemokine receptor-4 enhances the pulmonary metastatic potential of murine B16 melanoma cells | Q78710357 | ||
| CXC chemokine receptor 4 expression and function in human anaplastic thyroid cancer cells | Q78767913 | ||
| Association of CXCR4 and CCR7 chemokine receptor expression and lymph node metastasis in human cervical cancer | Q79219726 | ||
| SDF-1 plays a key role in the repairing and remodeling process on rat allo-orthotopic abdominal aorta grafts | Q79715671 | ||
| Recombination of CXCR4, VEGF, and MMP-9 predicting lymph node metastasis in human breast cancer | Q79790905 | ||
| Expression of growth factor and chemokine receptors: new insights in the biology of inflammatory breast cancer | Q79918235 | ||
| The SDF-1/CXCR4 ligand/receptor pair is an important contributor to several types of ocular neovascularization | Q80376104 | ||
| Chemokine receptor CXCR4 expression and prognosis in patients with metastatic prostate cancer | Q80506644 | ||
| Association between expression of vascular endothelial growth factor C, chemokine receptor CXCR4 and lymph node metastasis in colorectal cancer | Q80643044 | ||
| CXC chemokine receptor-4 antagonist blocks both growth of primary tumor and metastasis of head and neck cancer in xenograft mouse models | Q80726314 | ||
| A significant correlation between nuclear CXCR4 expression and axillary lymph node metastasis in hormonal receptor negative breast cancer | Q80975600 | ||
| CCR7 and CXCR4 as novel biomarkers predicting axillary lymph node metastasis in T1 breast cancer | Q81098644 | ||
| Chemokine receptor CXCR4 expression in breast cancer as a potential predictive marker of isolated tumor cells in bone marrow | Q81139820 | ||
| Possible involvement of SDF-1alpha/CXCR4-DPPIV axis in TGF-beta1-induced enhancement of migratory potential in human peritoneal mesothelial cells | Q81230145 | ||
| Preferential expression of chemokine receptor CXCR4 by highly malignant human gliomas and its association with poor patient survival | Q81325774 | ||
| Blockade of invasion and metastasis of breast cancer cells via targeting CXCR4 with an artificial microRNA | Q81340909 | ||
| Expression of CXCR4 is associated with axillary lymph node status in patients with early breast cancer | Q81379933 | ||
| Augmented mobilization and collection of CD34+ hematopoietic cells from normal human volunteers stimulated with granulocyte-colony-stimulating factor by single-dose administration of AMD3100, a CXCR4 antagonist | Q81487164 | ||
| Tumor-cell homing to lymph nodes and bone marrow and CXCR4 expression in esophageal cancer | Q82040938 | ||
| CXCR4 and VEGF expression in the primary site and the metastatic site of human osteosarcoma: analysis within a group of patients, all of whom developed lung metastasis | Q82782774 | ||
| Adenosine downregulates DPPIV on HT-29 colon cancer cells by stimulating protein tyrosine phosphatase(s) and reducing ERK1/2 activity via a novel pathway | Q83149943 | ||
| Expression of chemokine CXCL12 and its receptor CXCR4 in human epithelial ovarian cancer: an independent prognostic factor for tumor progression | Q83187267 | ||
| Chemokines and cancer | Q83278273 | ||
| Expression of chemokine receptors predicts the site of metastatic relapse in patients with axillary node positive primary breast cancer | Q48575675 | ||
| High expression of the chemokine receptor CXCR4 predicts extramedullary organ infiltration in childhood acute lymphoblastic leukaemia | Q48694724 | ||
| CXC chemokine receptor 4 expression and function in human astroglioma cells | Q49071824 | ||
| A pharmacokinetic-pharmacodynamic model for the mobilization of CD34+ hematopoietic progenitor cells by AMD3100. | Q50767910 | ||
| CXCR4-SDF-1 signaling is active in rhabdomyosarcoma cells and regulates locomotion, chemotaxis, and adhesion. | Q52834072 | ||
| Effect of chemokine receptors CXCR4 and CCR7 on the metastatic behavior of human colorectal cancer. | Q53276834 | ||
| Cyclooxygenase-2 expression: a significant prognostic indicator for patients with colorectal cancer. | Q53362101 | ||
| Selected eicosanoids increase the proliferation rate of human colon carcinoma cell lines and mouse colonocytes in vivo. | Q53461247 | ||
| A gene expression signature associated with metastatic cells in effusions of breast carcinoma patients. | Q53558013 | ||
| CXCR4 is a prognostic marker in acute myelogenous leukemia. | Q53607339 | ||
| The role of CXCR4 receptor expression in breast cancer: a large tissue microarray study. | Q53644477 | ||
| Differential expression of CXCR4 is associated with the metastatic potential of human non-small cell lung cancer cells. | Q54628926 | ||
| Chemokine receptor CXCR4 expression in colorectal cancer patients increases the risk for recurrence and for poor survival. | Q54669043 | ||
| Peroxisome proliferator-activated receptor gamma induces growth arrest and differentiation markers of human colon cancer cells. | Q54948587 | ||
| Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas | Q29620630 | ||
| Molecular biology of bone metastasis | Q30444749 | ||
| Differential activation of peroxisome proliferator-activated receptor-gamma by troglitazone and rosiglitazone | Q31399843 | ||
| Safety, pharmacokinetics, and antiviral activity of AMD3100, a selective CXCR4 receptor inhibitor, in HIV-1 infection. | Q33362778 | ||
| In vivo distribution of the human immunodeficiency virus/simian immunodeficiency virus coreceptors: CXCR4, CCR3, and CCR5. | Q33784206 | ||
| Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IkappaB kinase | Q33886831 | ||
| Pharmacokinetics and safety of AMD-3100, a novel antagonist of the CXCR-4 chemokine receptor, in human volunteers | Q33979799 | ||
| Structure and function of adenosine receptors and their genes. | Q34101838 | ||
| CXCR4/CXCL12 expression and signalling in kidney cancer | Q34123763 | ||
| Expression of cytosolic and group X secretory phospholipase A(2) genes in human colorectal adenocarcinomas | Q34131695 | ||
| Chemokine signaling and functional responses: the role of receptor dimerization and TK pathway activation. | Q34178157 | ||
| Mutations in the chemokine receptor gene CXCR4 are associated with WHIM syndrome, a combined immunodeficiency disease | Q34190328 | ||
| CXCR4 knockdown by small interfering RNA abrogates breast tumor growth in vivo | Q34357222 | ||
| Patients with adenomatous polyps and carcinomas have increased colonic mucosal prostaglandin E2 | Q34378716 | ||
| An overview on biological mechanisms of PPARs. | Q34381038 | ||
| Trafficking of normal stem cells and metastasis of cancer stem cells involve similar mechanisms: pivotal role of the SDF-1-CXCR4 axis | Q34418159 | ||
| The use of AMD3100 plus G-CSF for autologous hematopoietic progenitor cell mobilization is superior to G-CSF alone | Q34418466 | ||
| International Union of Pharmacology. XLVI. G protein-coupled receptor list. | Q34421152 | ||
| The prostaglandin E2 receptor EP2 is required for cyclooxygenase 2-mediated mammary hyperplasia | Q34423141 | ||
| COX-2: a target for colon cancer prevention | Q34504020 | ||
| Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2. | Q34568144 | ||
| Adenosine down-regulates the surface expression of dipeptidyl peptidase IV on HT-29 human colorectal carcinoma cells: implications for cancer cell behavior | Q35102870 | ||
| The bicyclam AMD3100 story | Q35158014 | ||
| Differential expression of cyclooxygenase 2 in human colorectal cancer | Q35357611 | ||
| 15-deoxy-delta 12,14-prostaglandin J2 inhibits multiple steps in the NF-kappa B signaling pathway. | Q35698498 | ||
| Role of prostaglandin E2-dependent angiogenic switch in cyclooxygenase 2-induced breast cancer progression | Q35735316 | ||
| Vascular endothelial growth factor and basic fibroblast growth factor induce expression of CXCR4 on human endothelial cells: In vivo neovascularization induced by stromal-derived factor-1alpha. | Q35786830 | ||
| The significance of cancer cell expression of the chemokine receptor CXCR4. | Q35832343 | ||
| Tumor microenvironmental physiology and its implications for radiation oncology | Q35837012 | ||
| CXCR4/CXCL12 axis promotes VEGF-mediated tumor angiogenesis through Akt signaling pathway | Q36003309 | ||
| The role of prostaglandins and other eicosanoids in the gastrointestinal tract | Q36123763 | ||
| Matrigel: basement membrane matrix with biological activity | Q36173565 | ||
| Regulation of the chemokine receptor CXCR4 by hypoxia | Q36371842 | ||
| The chemokine SDF-1 is a chemoattractant for human CD34+ hematopoietic progenitor cells and provides a new mechanism to explain the mobilization of CD34+ progenitors to peripheral blood. | Q36376700 | ||
| Recapitulation of short RNA-directed translational gene silencing in vitro | Q56899069 | ||
| Blockade of the Stromal Cell–Derived Factor-1/CXCR4 Axis AttenuatesIn vivoTumor Growth by Inhibiting Angiogenesis in a Vascular Endothelial Growth Factor–Independent Manner | Q57078137 | ||
| CXCL12-3′A Polymorphism and lung cancer metastases protection: new perspectives in immunotherapy? | Q58835521 | ||
| Use of the stromal cell-derived factor-1/CXCR4 pathway in prostate cancer metastasis to bone | Q60504419 | ||
| Expression of tumour necrosis factor (TNFα) and its receptors in benign and malignant breast tissue | Q61819262 | ||
| Inhibitory effects of anti-CXCR4 antibodies on human colon cancer cells | Q63247802 | ||
| Expression of CXCR4 Predicts Poor Prognosis in Patients with Malignant Melanoma | Q63247804 | ||
| Differences of metabolism of prostaglandin E2 and F2 alpha by decidual stromal cells and macrophages in culture | Q67856549 | ||
| delta 12-Prostaglandin J2, an ultimate metabolite of prostaglandin D2 exerting cell growth inhibition | Q69835332 | ||
| Albumin-catalyzed metabolism of prostaglandin D2. Identification of products formed in vitro | Q70915009 | ||
| Overexpression of the chemokine receptor CXCR4 in B cell chronic lymphocytic leukemia is associated with increased functional response to stromal cell-derived factor-1 (SDF-1) | Q73283069 | ||
| The extracellular fluid of solid carcinomas contains immunosuppressive concentrations of adenosine | Q73470605 | ||
| The chemokine receptor CXCR4 is required for outgrowth of colon carcinoma micrometastases | Q73608635 | ||
| Overexpression of cyclooxygenase-2 is sufficient to induce tumorigenesis in transgenic mice | Q73693790 | ||
| T140 analogs as CXCR4 antagonists identified as anti-metastatic agents in the treatment of breast cancer | Q73847638 | ||
| CXCR4 neutralization, a novel therapeutic approach for non-Hodgkin's lymphoma | Q74198916 | ||
| CXCR4 expression is associated with survival in familial chronic lymphocytic leukemia, but CD38 expression is not | Q74545601 | ||
| A possible role for CXCR4 and its ligand, the CXC chemokine stromal cell-derived factor-1, in the development of bone marrow metastases in neuroblastoma | Q74601897 | ||
| Inhibitory effects of prostaglandin D2 against the proliferation of human colon cancer cell lines and hepatic metastasis from colorectal cancer | Q77063686 | ||
| Activation of PPARgamma leads to inhibition of anchorage-independent growth of human colorectal cancer cells | Q77494182 | ||
| TNF-alpha in promotion and progression of cancer | Q36585132 | ||
| Dissemination of hepatocellular carcinoma is mediated via chemokine receptor CXCR4. | Q36612087 | ||
| Bone-derived SDF-1 stimulates IL-6 release via CXCR4, ERK and NF-kappaB pathways and promotes osteoclastogenesis in human oral cancer cells | Q36838004 | ||
| Breast cancer brain metastases | Q36918681 | ||
| Silencing of CXCR4 blocks breast cancer metastasis | Q37074006 | ||
| A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors. | Q37089440 | ||
| Prostaglandin levels in human colorectal mucosa: effects of sulindac in patients with familial adenomatous polyposis | Q37237357 | ||
| Effects of ligand activation of peroxisome proliferator-activated receptor gamma in human prostate cancer | Q37269372 | ||
| Prostaglandin H synthase 2 is expressed abnormally in human colon cancer: evidence for a transcriptional effect | Q37605758 | ||
| 15-Deoxy-{delta}12,14-prostaglandin j2 inhibits interleukin-1{beta}-induced nuclear factor-{kappa}b in human amnion and myometrial cells: mechanisms and implications | Q38329568 | ||
| Inactivation of HIV-1 chemokine co-receptor CXCR-4 by a novel intrakine strategy | Q38941762 | ||
| Inhibition of CXCR4 activity with AMD3100 decreases invasion of human colorectal cancer cells in vitro | Q39991423 | ||
| Up-regulation of stromal cell-derived factor-1alpha and its receptor CXCR4 expression accompanied with epithelial-mesenchymal transition in human oral squamous cell carcinoma. | Q39999861 | ||
| Regulation of CXCR4 by the Notch ligand delta-like 4 in endothelial cells | Q40002532 | ||
| 15-Deoxy-delta(12,14)-prostaglandin J(2) down-regulates CXCR4 on carcinoma cells through PPARgamma- and NFkappaB-mediated pathways. | Q40091899 | ||
| Role of CXCL12 in metastasis of human ovarian cancer. | Q40094482 | ||
| Blocking on the CXCR4/mTOR signalling pathway induces the anti-metastatic properties and autophagic cell death in peritoneal disseminated gastric cancer cells | Q40108758 | ||
| Rho activation regulates CXCL12 chemokine stimulated actin rearrangement and restitution in model intestinal epithelia. | Q40119156 | ||
| Thiazolidinedione drugs down-regulate CXCR4 expression on human colorectal cancer cells in a peroxisome proliferator activated receptor gamma-dependent manner. | Q40153588 | ||
| Hypoxia-inducible factor 1 and VEGF upregulate CXCR4 in glioblastoma: implications for angiogenesis and glioma cell invasion | Q40213967 | ||
| Adenosine upregulates CXCR4 and enhances the proliferative and migratory responses of human carcinoma cells to CXCL12/SDF-1alpha. | Q40258406 | ||
| Lower expression of CXCR4 in lymph node metastases than in primary breast cancers: potential regulation by ligand-dependent degradation and HIF-1alpha | Q40271040 | ||
| Overexpression of both CXC chemokine receptor 4 and vascular endothelial growth factor proteins predicts early distant relapse in stage II-III colorectal cancer patients | Q40283597 | ||
| Role of the CXCL12/CXCR4 axis in peritoneal carcinomatosis of gastric cancer | Q40314315 | ||
| The inflammatory cytokine tumor necrosis factor-alpha regulates chemokine receptor expression on ovarian cancer cells | Q40351465 | ||
| The elevated level of CXCR4 is correlated with nodal metastasis of human breast cancer | Q40363410 | ||
| Activation of chemokine receptor CXCR4 in malignant glioma cells promotes the production of vascular endothelial growth factor | Q40387859 | ||
| CXCL-12/stromal cell-derived factor-1alpha transactivates HER2-neu in breast cancer cells by a novel pathway involving Src kinase activation | Q40390514 | ||
| Suppression of prostate tumor cell growth by stromal cell prostaglandin D synthase-derived products | Q40396841 | ||
| Diverse signaling pathways through the SDF-1/CXCR4 chemokine axis in prostate cancer cell lines leads to altered patterns of cytokine secretion and angiogenesis | Q40400042 | ||
| The expression of functional chemokine receptor CXCR4 is associated with the metastatic potential of human nasopharyngeal carcinoma | Q40401192 | ||
| SDF-1 and CXCR4 are up-regulated by VEGF and contribute to glioma cell invasion. | Q40406965 | ||
| Characterization and enumeration of cells secreting tumor markers in the peripheral blood of breast cancer patients. | Q40417804 | ||
| Expression of CXCR4 and its down-regulation by IFN-gamma in head and neck squamous cell carcinoma | Q40429792 | ||
| Messenger RNA expression levels of CXCR4 correlate with metastatic behavior and outcome in patients with osteosarcoma | Q40438081 | ||
| CXCR4 chemokine receptor and integrin signaling co-operate in mediating adhesion and chemoresistance in small cell lung cancer (SCLC) cells. | Q40439589 | ||
| Alpha,beta-unsaturated ketone is a core moiety of natural ligands for covalent binding to peroxisome proliferator-activated receptor gamma. | Q40461294 | ||
| Increased survival, proliferation, and migration in metastatic human pancreatic tumor cells expressing functional CXCR4. | Q40490606 | ||
| 15-Deoxy-delta 12,14-prostaglandin J2 induces apoptosis in human malignant B cells: an effect associated with inhibition of NF-kappa B activity and down-regulation of antiapoptotic proteins. | Q40501213 | ||
| CXCL12-CXCR4 interactions modulate prostate cancer cell migration, metalloproteinase expression and invasion | Q40507455 | ||
| Interaction of ligand-receptor system between stromal-cell-derived factor-1 and CXC chemokine receptor 4 in human prostate cancer: a possible predictor of metastasis | Q40538377 | ||
| Involvement of the chemokine receptor CXCR4 and its ligand stromal cell-derived factor 1alpha in breast cancer cell migration through human brain microvascular endothelial cells | Q40538962 | ||
| A single treatment with microcapsules containing a CXCR4 antagonist suppresses pulmonary metastasis of murine melanoma | Q40543358 | ||
| Inhibition of breast cancer metastasis by selective synthetic polypeptide against CXCR4. | Q40543795 | ||
| Role of high expression levels of CXCR4 in tumor growth, vascularization, and metastasis | Q40548697 | ||
| Stromal cell-derived factor-1alpha-induced cell proliferation and its possible regulation by CD26/dipeptidyl peptidase IV in endometrial adenocarcinoma | Q40555406 | ||
| Stromal cell-derived factor-1alpha promotes melanoma cell invasion across basement membranes involving stimulation of membrane-type 1 matrix metalloproteinase and Rho GTPase activities. | Q40570934 | ||
| Glutathione S-transferases (GSTs) inhibit transcriptional activation by the peroxisomal proliferator-activated receptor gamma (PPAR gamma) ligand, 15-deoxy-delta 12,14prostaglandin J2 (15-d-PGJ2). | Q40586826 | ||
| Stromal-derived factor-1alpha/CXCL12-CXCR 4 axis is involved in the dissemination of NSCLC cells into pleural space | Q40607879 | ||
| Chemokine receptor CXCR4 downregulated by von Hippel-Lindau tumour suppressor pVHL. | Q40633683 | ||
| Regulation of cellular proliferation, cytoskeletal function, and signal transduction through CXCR4 and c-Kit in small cell lung cancer cells | Q40692637 | ||
| Multiple actions of the chemokine CXCL12 on epithelial tumor cells in human ovarian cancer | Q40696855 | ||
| T0070907, a selective ligand for peroxisome proliferator-activated receptor gamma, functions as an antagonist of biochemical and cellular activities | Q40747044 | ||
| Prostaglandin E2 transactivates EGF receptor: a novel mechanism for promoting colon cancer growth and gastrointestinal hypertrophy | Q40747279 | ||
| 15-deoxy-delta 12,14-prostaglandin J2. A prostaglandin D2 metabolite generated during inflammatory processes | Q40757735 | ||
| Expression of functional chemokine receptors CXCR3 and CXCR4 on human melanoma cells | Q40778652 | ||
| The SDF-1-CXCR4 axis stimulates VEGF secretion and activates integrins but does not affect proliferation and survival in lymphohematopoietic cells. | Q40780948 | ||
| Expression of stromal cell-derived factor 1 and CXCR4 ligand receptor system in pancreatic cancer: a possible role for tumor progression | Q40853389 | ||
| Influence of J series prostaglandins on apoptosis and tumorigenesis of breast cancer cells | Q40925778 | ||
| Structure and chromosomal localization of the human stromal cell-derived factor 1 (SDF1) gene | Q41312923 | ||
| Chemokine receptor expression by human intestinal epithelial cells | Q41681584 | ||
| Role of prostaglandin E2 receptors in migration of murine and human breast cancer cells. | Q42450323 | ||
| Chemokine receptor expression in non-melanoma skin cancer | Q42525321 | ||
| A potent antidiabetic thiazolidinedione with unique peroxisome proliferator-activated receptor gamma-activating properties | Q42538023 | ||
| Vascular endothelial growth factor promotes breast carcinoma invasion in an autocrine manner by regulating the chemokine receptor CXCR4. | Q42807023 | ||
| Upregulation of CXCR4 is essential for HER2-mediated tumor metastasis. | Q42823593 | ||
| Characteristics of the peroxisome proliferator activated receptor gamma (PPARgamma) ligand induced apoptosis in colon cancer cells | Q43006369 | ||
| Prostaglandin synthesis in human T cells: its partial inhibition by lectins and anti-CD3 antibodies as a possible step in T cell activation. | Q43487588 | ||
| Chemokine stromal cell-derived factor-1alpha modulates VLA-4 integrin-mediated multiple myeloma cell adhesion to CS-1/fibronectin and VCAM-1. | Q43518303 | ||
| Epithelial cancer cell migration: a role for chemokine receptors? | Q43657321 | ||
| Adenosine acts through an A3 receptor to prevent the induction of murine anti-CD3-activated killer T cells. | Q43981136 | ||
| Functional consequences of cysteine modification in the ligand binding sites of peroxisome proliferator activated receptors by GW9662. | Q44001857 | ||
| Expression of cyclooxygenase-2 and peroxisome proliferator-activated receptor-gamma and levels of prostaglandin E2 and 15-deoxy-delta12,14-prostaglandin J2 in human breast cancer and metastasis | Q44231772 | ||
| Expression of the chemokine receptor CXCR4 and its ligand stromal cell-derived factor 1 in human brain tumors and their involvement in glial proliferation in vitro | Q44251647 | ||
| Peroxisome proliferator-activated receptor gamma agonists induce proteasome-dependent degradation of cyclin D1 and estrogen receptor alpha in MCF-7 breast cancer cells. | Q44342291 | ||
| Multidrug resistance protein (MRP) 1 and MRP3 attenuate cytotoxic and transactivating effects of the cyclopentenone prostaglandin, 15-deoxy-Delta(12,14)prostaglandin J2 in MCF7 breast cancer cells | Q44430440 | ||
| Immunohistochemical expression of cyclooxygenase isoenzymes and downstream enzymes in human lung tumors. | Q44435157 | ||
| CXCR4 enhances adhesion of B16 tumor cells to endothelial cells in vitro and in vivo via beta(1) integrin | Q44635459 | ||
| Inhibition of activator protein 1 activation, vascular endothelial growth factor, and cyclooxygenase-2 expression by 15-deoxy-Delta12,14-prostaglandin J2 in colon carcinoma cells: evidence for a redox-sensitive peroxisome proliferator-activated rece | Q45003981 | ||
| Prostaglandin E2 enhances intestinal adenoma growth via activation of the Ras-mitogen-activated protein kinase cascade | Q45309112 | ||
| The effects of prostaglandin A2 on cell growth, cell cycle status and apoptosis induction in HeLa and MCF-7 cells. | Q46334228 | ||
| Characterization of the CXCR4 signaling in pancreatic cancer cells | Q46823256 | ||
| High molecular weight phospholipase A2 and fatty acids in human colon tumours and associated normal tissue | Q47325239 | ||
| Functional expression of the CXCR4 chemokine receptor is induced by RET/PTC oncogenes and is a common event in human papillary thyroid carcinomas | Q47376060 | ||
| CXCL12 and vascular endothelial growth factor synergistically induce neoangiogenesis in human ovarian cancers. | Q47853213 | ||
| Expression of CXCR4 and CXCL12 (SDF-1) in human prostate cancers (PCa) in vivo | Q47895026 | ||
| Chemokine receptor CXCR4 and early-stage non-small cell lung cancer: pattern of expression and correlation with outcome | Q47917544 | ||
| CXCR4 is expressed in ductal carcinoma in situ of the breast and in atypical ductal hyperplasia | Q47936188 | ||
| Rapid mobilization of CD34+ cells following administration of the CXCR4 antagonist AMD3100 to patients with multiple myeloma and non-Hodgkin's lymphoma | Q47951335 | ||
| Nestin, PDGFRbeta, CXCL12 and VEGF in glioma patients: different profiles of (pro-angiogenic) molecule expression are related with tumor grade and may provide prognostic information. | Q48115693 | ||
| CXCR-4, a chemokine receptor, is overexpressed in and required for proliferation of glioblastoma tumor cells | Q48354586 | ||
| CXCR4 is a major chemokine receptor on glioma cells and mediates their survival | Q48464729 | ||
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P304 | page(s) | 769413 | |
| P577 | publication date | 2008-01-01 | |
| P1433 | published in | PPAR Research | Q15756406 |
| P1476 | title | CXCR4 in Cancer and Its Regulation by PPARgamma | |
| P478 | volume | 2008 |
Search more.